Y
Yoshikazu Inoue
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 273
Citations - 17662
Yoshikazu Inoue is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 48, co-authored 233 publications receiving 12648 citations. Previous affiliations of Yoshikazu Inoue include Niigata University.
Papers
More filters
Journal ArticleDOI
Airway-centered Fibroelastosis Accompanied by Subpleural Lesions of Unknown Cause in a Young Man Who Later Developed Pulmonary Hypertension.
Shojiro Minomo,Toru Arai,Kazunobu Tachibana,Hideo Matsui,Takahiko Kasai,Masanori Akira,Yoshikazu Inoue +6 more
TL;DR: A 26-year-old man with a history of bronchial asthma was found to have high-density shadows along the bronchovascular bundle and in the subpleural area on computed tomography of the chest and diagnosed with airway-centered fibroelastosis of unknown cause after multidisciplinary discussions.
Journal ArticleDOI
Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists
Tomoyuki Fujisawa,Norimichi Akiyama,Tatsuya Morita,Takafumi Koyauchi,Yoshinobu Matsuda,M. Morii,Mitsunori Miyashita,Ryo Tachikawa,Keisuke Tomii,Hiromi Tomioka,Satoshi Hagimoto,Yasuhiro Kondoh,Yoshikazu Inoue,Takafumi Suda +13 more
TL;DR: In this paper , the authors addressed palliative care for interstitial lung disease (ILD) patients with high symptom burdens and poor prognosis, and found that patients with ILD need optimal palliate care to maintain their quality of life.
Journal ArticleDOI
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study.
Nobutaka Kitamura,Kuniaki Seyama,Yoshikazu Inoue,Katsura Nagai,Masaru Suzuki,Hiroshi Moriyama,Toshinori Takada,Ryushi Tazawa,Toyohiro Hirai,Michiaki Mishima,Mie Hayashida,Masaki Hirose,Toru Arai,Chikatoshi Sugimoto,Noboru Hattori,Kentaro Watanabe,Tsutomu Tamada,Kohei Akazawa,Takahiro Tanaka,Koh Nakata +19 more
TL;DR: This work investigated the association of stomatitis incidence with patient background data and treatment parameters, using data from the multicenter long‐term sirolimus trial, to identify risk factors.
Journal ArticleDOI
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial
Yoshikazu Inoue,Athol U. Wells,Jin Woo Song,Zuojun Xu,Hideya Kitamura,Takafumi Suda,Masaki Okamoto,Heiko Müller,Carl Coeck,Klaus B. Rohr,Martin Kolb,Kevin K. Brown +11 more
TL;DR: In the INBUILD trial in patients with progressive fibrosing interstitial lung diseases (ILDs), nintedanib reduced the rate of decline in forced vital capacity (FVC) with an adverse event profile characterized mainly by gastrointestinal events as discussed by the authors .
Journal Article
Enhanced expression of angiotensin II type 1 receptor in usual interstitial pneumonia.
Yoshimi Sugama,Yoshihiro Ikura,Noriko Yoshimi,Takehisa Suekane,Chizuko Kitabayashi,Masashi Nakagawa,Masahiko Ohsawa,M Kitaichi,Satoru Yamamoto,Yoshikazu Inoue,Kazuto Hirata,Makiko Ueda +11 more
TL;DR: Angiotensin II and its type 1 receptor play a profibrogenic role in idiopathic interstitial pneumonias, particularly in usual interstitial pneumonia, and smooth muscle cells increased in diseased lung tissues may be contractile and may contribute to reduction of airspaces in usualinterstitial pneumonia.